Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_000548.5(TSC2):c.391C>T(p.Pro131Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 16-2054350-C-T is Benign according to our data. Variant chr16-2054350-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1384186.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}.
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The p.P131S variant (also known as c.391C>T), located in coding exon 4 of the TSC2 gene, results from a C to T substitution at nucleotide position 391. The proline at codon 131 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Tuberous sclerosis 2 Benign:1
Nov 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);.;Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);.;Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);Loss of methylation at K128 (P = 0.0627);.;